NCT03070132View on ClinicalTrials.gov

802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 19, 2023

Primary Completion Date

October 14, 2025

Study Completion Date

August 21, 2026

Conditions

Trigeminal Neuralgia

Interventions

DRUG

BIIB074

Administered as specified in the treatment arm

DRUG

Placebo

Matched placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY